Axonics Modular Technologies
Novel sacral neuromodulation system for treating overactive bladder
Axonics has developed a novel and potentially best-in-class implantable sacral neuromodulation (SNM) system for the treatment of overactive bladder and faecal incontinence.
It will be the smallest fully implantable, and first rechargeable SNM device, and is expected to work in the body for up to 15 years.
CEO Raymond Cohen